लोड हो रहा है...
Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells
BACKGROUND: The poor outcomes for patients diagnosed with acute myeloid leukemia (AML) are largely attributed to leukemia stem cells (LSCs) which are difficult to eliminate with conventional therapy and responsible for relapse. Thus, new therapeutic strategies which could selectively target LSCs in...
में बचाया:
| में प्रकाशित: | J Hematol Oncol |
|---|---|
| मुख्य लेखकों: | , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
BioMed Central
2016
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5034521/ https://ncbi.nlm.nih.gov/pubmed/27658462 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-016-0327-5 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|